Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Payal P. Kakadiya
Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-positive Patients Ingesting Dabigatran
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Abacavir/Lamivudine Versus Tenofovir/Emtricitabine in Virologically Suppressed Patients Switching From Ritonavir-Boosted Protease Inhibitors to Raltegravir
AIDS Research and Human Retroviruses
Virology
Infectious Diseases
Immunology
Pharmacokinetic Interactions Between the HCV Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, or Darunavir in Healthy Participants
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Oral Candidiasis in HIV+ Patients Under Treatment With Protease Inhibitors
Brazilian Oral Research
HIV Protease Inhibitors and Obesity
Current Opinion in Endocrinology, Diabetes and Obesity
Internal Medicine
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Protease Inhibitors Prevent Plasminogen-Mediated, but Not Pemphigus Vulgaris-Induced, Acantholysis in Human Epidermis
Biological Chemistry
Biochemistry
Clinical Biochemistry
Molecular Biology
Real-Life Study of Dual Therapy Based on Dolutegravir and Ritonavir-Boosted Darunavir in HIV-1-infected Treatment-Experienced Patients
PLoS ONE
Multidisciplinary
Detection of Drug-Induced Dyslipidaemia in HIV-positive Patients Treated With Protease Inhibitors in a South African District – A Retrospective Study
Tropical Journal of Pharmaceutical Research
Pharmacology
Pharmaceutical Science
Clinical Validation and Applicability of Different Tipranavir/Ritonavir Genotypic Scores in HIV-1 Protease Inhibitor-Experienced Patients
Current HIV Research
Virology
Infectious Diseases
An Observational Study in an Urban Ugandan Clinic Comparing Virological Outcomes of Patients Switched From First-Line Antiretroviral Regimens to Second-Line Regimens Containing Ritonavir-Boosted Atazanavir or Ritonavir-Boosted Lopinavir
BMC Infectious Diseases
Infectious Diseases
